121 related articles for article (PubMed ID: 26392778)
21. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
22. Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas.
Yang Y; Liang S; Li Y; Gao F; Zheng L; Tian S; Yang P; Li L
Oncol Lett; 2017 Dec; 14(6):7179-7184. PubMed ID: 29344149
[TBL] [Abstract][Full Text] [Related]
23. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M
Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032
[TBL] [Abstract][Full Text] [Related]
24. High Serum HDGF Levels Are Predictive of Bone Metastasis and Unfavorable Prognosis in Non-Small Cell Lung Cancer.
Zhang G; Liu Z; Chen Y; Zhang Y
Tohoku J Exp Med; 2017 Jun; 242(2):101-108. PubMed ID: 28592712
[TBL] [Abstract][Full Text] [Related]
25. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
26. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
27. [Expression of hepatoma-derived growth factor and its clinical implication in stage I non-small cell lung cancer].
Zhou S; Xu S; Zhang H; Liu Z; Liang Z; Song X; Jiang Y; Zhao D
Zhongguo Fei Ai Za Zhi; 2007 Aug; 10(4):291-5. PubMed ID: 21122296
[TBL] [Abstract][Full Text] [Related]
28. Expression of hepatoma-derived growth factor in hepatocarcinogenesis.
Yoshida K; Nakamura H; Okuda Y; Enomoto H; Kishima Y; Uyama H; Ito H; Hirasawa T; Inagaki S; Kawase I
J Gastroenterol Hepatol; 2003 Nov; 18(11):1293-301. PubMed ID: 14535987
[TBL] [Abstract][Full Text] [Related]
29. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.
Enomoto H; Nakamura H; Liu W; Nishiguchi S
Int J Mol Sci; 2015 Jun; 16(6):14086-97. PubMed ID: 26101867
[TBL] [Abstract][Full Text] [Related]
30. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH
Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
[TBL] [Abstract][Full Text] [Related]
31. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
[TBL] [Abstract][Full Text] [Related]
32. MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor.
Sun B; Gu X; Chen Z; Xiang J
Am J Cancer Res; 2015; 5(12):3635-44. PubMed ID: 26885452
[TBL] [Abstract][Full Text] [Related]
33. The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.
Tang J; Shi H; Li H; Zhen T; Dong Y; Zhang F; Yang Y; Han A
Tumour Biol; 2016 Aug; 37(8):10287-301. PubMed ID: 26842923
[TBL] [Abstract][Full Text] [Related]
34. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
[TBL] [Abstract][Full Text] [Related]
35. Development and clinical evaluation of a multi-purpose mAb and a sandwich ELISA test for hepatoma-derived growth factor in lung cancer patients.
Zhang A; Long W; Guo Z; Liu G; Hu Z; Huang Y; Li Y; Grabinski TM; Yang J; Zhao PX; Everett AD; Zhang Y; Cao BB
J Immunol Methods; 2010 Apr; 355(1-2):61-7. PubMed ID: 20193688
[TBL] [Abstract][Full Text] [Related]
36. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
Uyama H; Tomita Y; Nakamura H; Nakamori S; Zhang B; Hoshida Y; Enomoto H; Okuda Y; Sakon M; Aozasa K; Kawase I; Hayashi N; Monden M
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6043-8. PubMed ID: 17062679
[TBL] [Abstract][Full Text] [Related]
37. Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells.
Lee KH; Choi EY; Kim MK; Lee SH; Jang BI; Kim TN; Kim SW; Kim SW; Song SK; Kim JR; Jung BC
Oncol Res; 2010; 19(2):67-76. PubMed ID: 21302807
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
Song R; Cong L; Ni G; Chen M; Sun H; Sun Y; Chen M
Oncol Lett; 2017 Jul; 14(1):767-775. PubMed ID: 28693232
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
Zheng Y; Lu S; Xu Y; Zheng J
Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
[TBL] [Abstract][Full Text] [Related]
40. Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors.
Chang KC; Tai MH; Lin JW; Wang CC; Huang CC; Hung CH; Chen CH; Lu SN; Lee CM; Changchien CS; Hu TH
Int J Cancer; 2007 Sep; 121(5):1059-65. PubMed ID: 17487837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]